Literature DB >> 18843257

Variability of ferritin measurements in chronic kidney disease; implications for iron management.

Bradley A Ford1, Daniel W Coyne, Charles S Eby, Mitchell G Scott.   

Abstract

Serum ferritin levels are a proxy measure of iron stores; and existing guidelines for managing anemia in hemodialysis patients suggest that serum ferritin concentrations should be maintained at >200 ng/ml. The KDOQI recommendations further state there is insufficient evidence advocating routine intravenous iron when ferritin levels exceed 500 ng/ml. Here we determined the interassay differences and short-term intraindividual variability of serum ferritin measurements in patients on chronic hemodialysis to illustrate how these variances may affect treatment decisions. Intermethod variations of up to 150 ng/ml were found comparing six commonly used ferritin assays that evaluated thirteen pools of serum from hemodialysis and nonhemodialysis patients. The intraindividual variability for ferritin in 60 stable hemodialysis patients ranged between 2-62% measured over an initial two-week period and from 3-52% when factored over a six-week period. Our results suggests that single serum ferritin values should not be used to guide clinical decisions regarding treatment of chronic hemodialysis patients with intravenous iron due to significant analytical and intraindividual variability.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18843257     DOI: 10.1038/ki.2008.526

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  16 in total

1.  The conundrum of serum ferritin measurement in patients with chronic kidney disease.

Authors:  Der-Cherng Tarng
Journal:  Nat Clin Pract Nephrol       Date:  2008-12-09

2.  Coefficient of variation among ferritin measurement methods in hemodialysis and standard serum ferritin level.

Authors:  Daigo Kamei; Takashi Akiba
Journal:  Kidney Int       Date:  2015-07       Impact factor: 10.612

3.  The Authors Reply.

Authors:  Takahiro Kuragano; Osamu Matsumura; Akihiko Matsuda; Taiga Hara; Hideyasu Kiyomoto; Toshiaki Murata; Kenichiro Kitamura; Shouichi Fujimoto; Hiroki Hase; Nobuhiko Joki; Atushi Fukatsu; Toru Inoue; Yukihiro Itakura; Takeshi Nakanishi
Journal:  Kidney Int       Date:  2015-07       Impact factor: 10.612

4.  Racial differences in restless legs symptoms and serum ferritin in an incident dialysis patient cohort.

Authors:  Nancy G Kutner; Rebecca Zhang; Yijian Huang; Donald L Bliwise
Journal:  Int Urol Nephrol       Date:  2012-01-05       Impact factor: 2.370

Review 5.  Markers of iron status in chronic kidney disease.

Authors:  Adam E Gaweda
Journal:  Hemodial Int       Date:  2017-03-22       Impact factor: 1.812

6.  Can the response to iron therapy be predicted in anemic nondialysis patients with chronic kidney disease?

Authors:  Simona Stancu; Liliana Bârsan; Ana Stanciu; Gabriel Mircescu
Journal:  Clin J Am Soc Nephrol       Date:  2009-12-17       Impact factor: 8.237

7.  Cumulative iron dose and resistance to erythropoietin.

Authors:  A Rosati; C Tetta; J I Merello; I Palomares; R Perez-Garcia; F Maduell; B Canaud; P Aljama Garcia
Journal:  J Nephrol       Date:  2014-08-05       Impact factor: 3.902

Review 8.  Iron dosing in kidney disease: inconsistency of evidence and clinical practice.

Authors:  Adam E Gaweda; Yelena Z Ginzburg; Yossi Chait; Michael J Germain; George R Aronoff; Eliezer Rachmilewitz
Journal:  Nephrol Dial Transplant       Date:  2014-05-12       Impact factor: 5.992

9.  Chapter 2: Use of iron to treat anemia in CKD.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2012-08

10.  Effect of systemic inflammation on level of ferritin seminal in chronic renal male patient undergoing hemodialysis.

Authors:  Gilmar Pereira Silva; Carlos Daniel De La Vega Elena; Fabiana Pirani Carneiro; Joel Paulo Russomano Veiga
Journal:  Int Arch Med       Date:  2014-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.